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Abstract: Marine habitats harbour a large variety of organisms that belong to diverse taxa; from
bacteria and unicellular eukaryotes to fungi, animals, and plants. Although we have only started
to understand the diversity and structure of marine communities, it is clear that numerous marine
species have or might have an impact on human health. Some are a source of natural products with
potential or actual medical applications, others are toxic and harmful to humans, and some are used
in biomedical research to help understand the molecular basis of human diseases. New molecular
genetics and genomic methods provide powerful and ever more indispensable tools for studying
marine organisms and all aspects of their influence on human health. Herein, we present work using
the latest research, which mostly uses genomics, to tackle the questions related with the topic of
the issue.
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The aim of this special issue was to provide insight into the field of research on genetics and
genomics of marine organisms linked with human health. Marine habitats harbour a large variety
of organisms that belong to diverse taxa; from bacteria and unicellular eukaryotes to fungi, animals,
and plants. Although we have only started to understand the diversity and structure of marine
communities, it is clear that numerous marine species have or might have an impact on human health.
Some are a source of natural products with potential or actual medical applications, others are toxic
and harmful to humans, and some are used in biomedical research to help understand the molecular
basis of human diseases. New molecular genetics and genomic methods provide powerful and ever
more indispensable tools for studying marine organisms and all aspects of their influence on human
health. Herein, we present work using the latest research, which mostly uses genomics, to tackle
the questions related with the topic of the issue.
This Special Issue contains eight research articles on different topics related to genetics and
genomics of marine organisms associated with human health. In the following sections, we would like
to provide a short overview of what the reader will find in this Special Issue.
Jia and colleagues report a high-quality genome with a relatively complete gene set for the Chinese
white dolphin (Sousa chinensis). They discovered that the expansion of certain gene families, especially
the increase in immune and sensory genes, could shed some light on the molecular mechanisms
for adaptation to the nearshore environments. Furthermore, they observed a serious bottleneck in
the demographic population history of Chinese white dolphin before the Mindel glaciation (about
350,000 years ago). In addition, a comparative genomic survey on antihypertensive peptides (AHTPs)
increases knowledge about the potential of mammal proteins for development of antihypertensive
peptides. Genome assembly of Chinese White Dolphin provides a genetic resource for other studies on
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adaptive ecology, conservation biology of cetaceans and development of marine peptide-based drugs
for treatment of various human cardiovascular diseases [1].
Wang and colleagues provide a high-quality genome of the giant grouper (Epinephelus lanceolatus).
Giant groupers are of economic importance in marine aquaculture for their rapid growth, but
unfortunately bacterial and viral diseases have become the main threats to the grouper industry.
The authors identified antimicrobial peptide (AMP) genes systematically in groupers and, therefore,
support antimicrobial research and possibly provide suggestions for therapy. These genomics resources
will help in the effort against infectious diseases in the giant grouper industry [2].
Chen and colleagues generated a high-quality genome assembly of the Japanese eel (Anguilla
japonica). They also performed phylogenetic and synteny analyses, as well as variation determination of
24 tbx4 sequences in 22 representative teleost species. They determined, for the first time, an inversion
of a special tbx4 gene cluster that is potentially correlated with the evolutionary development of teleost
fin spines, which may benefit the development of novel marine drugs [3].
Bian and colleagues sequenced and assembled a draft genome of the blue tilapia (Oreochromis
aureus) for the first time. They performed a series of genomic analyses related to biology and
immunology (such as antimicrobial peptides (AMPs)) of the blue tilapia and genetic comparisons with
its close relative, the Nile tilapia (O. niloticus). They also predicted 23,117 protein-coding genes in
the blue tilapia genome. Comparisons of predicted antimicrobial peptides between the blue tilapia
and its close relative, the Nile tilapia, proved that these immunological genes are highly similar with
a genome-wide scattering distribution. Given that the blue tilapia has an important economic value, its
genome resource will build a valuable platform for further biomedical research and practical molecular
breeding of tilapias [4].
In their article, Gill and Kumara present a novel, alternative approach for testing developmental
neurotoxicity. This strategy is rapid and economically feasible with an acceptable predictive capacity, as
the previously used models do not necessarily reflect physiological differentiation processes involved
in neurogenesis, astrocytogenesis and oligodendrocytogenesis. They chose rat neuronal stem cells
(rNSC) as a model system, which will enable usage of dose ranges that are measured in humans in
a high-throughput mode, testing multiple chemicals simultaneously at a much lower cost. As a test
chemical, the authors used domoic acid (DA) produced in blooms of different marine species such
as species of Pseudo-nitzschia or red alga and ochratoxin A, a mycotoxin produced in Aspergilli and
Penicilia molds. The test showed that both non-cytotoxic and cytotoxic concentrations of DA and OTA
reduced the differentiation of rNSC into astrocytes, neurons and oligodendrocytes, which indicates
that low, non-cytotoxic concentrations of these compounds interfere with the differentiation of rNCS.
This proves that the rNSC system is beneficial in these kind of investigations [5].
The work of Perina et al. reports new findings on one of the poorly studied members of
the NME/NDPK family of genes/proteins. Nucleoside diphosphate kinase are a family of enzymes
that transfer the terminal phosphate from NTPs (mostly ATP) to other d(NDPs). All of the members
of the NME/NDPK family possess the NDK domain but only NME1–NME4 exhibit NDPK activity.
The NME/NDPKs have been linked to many human diseases such as metastasis regulation and
cardiac diseases. The authors report on the NME5 homologue from an early branching eukaryotic
lineage, the red alga Chondrus crispus. The ancestral type protein is, unlike its human homologue,
a functional multimeric NDPK with high affinity to various types of DNA. Its overexpression inhibits
cell proliferation and the anchorage-independent growth of cells in soft agar, but has no impact on
apoptosis. It seems that the ancestral gene has changed during eukaryotic evolution, probably together
with its protein function [6].
Seahorses are well known for their special shape and male pregnancy but have also been
an important resource for traditional Chinese medicine. Five seahorse species have been applied in
the production of these medicines, especially the lined seahorse (Hippocampus erectus). Large-scale
aquaculture of seahorses has lately been seriously limited due to fatal diseases caused by external
pathogens such as vibrio or ciliate. The antibiotic applied often causes drug resistance and residual
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drug issues; therefore, finding novel antibacterial alternatives to secure seahorse and other aquaculture
populations is urgent. In their work, Chen and coworkers analyzed putative antimicrobial peptides
(AMP) from the previously studied genome and transcriptome studies of the lined seahorse in
a high-throughput manner and checked their transcriptional changes in various tissues during
development. Furthermore, differential expression between male and female individuals was also
analyzed for potential sexual variances and specificity. The data provides an overview of AMPs in
the popular lined seahorse, which is a solid foundation for further investigation on development of
AMP-based fish food and human drugs [7].
Ilamycins are bioactive antimicrobial cyclopeptides derived from marine Streptomyces. He et al.
report on the functions of four genes of the ilamycin biosynthetic gene cluster (ila BCG), including
two regulatory genes, a postive ilaA and a negative ilaB regulatory gene together with two transporter
genes (ila J and ilaK). The authors characterized the mentioned genes, used them to construct high-yield
strains and expressed the biosynthetic gene cluster of ilamycin in Streptomyces coelicolor 1152. These
results lay a rather good foundation for further exploration but also provide basic genetic elements for
synthetic biology [8].
As guest editors, we are grateful to all the authors who contributed their excellent results to
the special issue, all the reviewers who carefully evaluated the submitted manuscripts, and the editorial
boards of Marine Drugs, and Vincent Di, Assistant Editor, for their support and kind help.
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